Dan Hartman
Dan Hartman publishes mostly in Economics and Econometrics, Public Health, Environmental and Occupational Health and Infectious Diseases, on topics such as Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Computational Drug Discovery Methods.
- World rank
- #2,386,352 of 7,710,434 ranked researchers
- Rank in United States
- #708,325 of 1,627,098
- Works
- 35
- Citations
- 430
- Citations per work
- 12.3
What does Dan Hartman research?
Dan Hartman's work is mostly in Medicine (25%), Economics, Econometrics and Finance (14%), Computer Science (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1953.8%
- Health Sciences925.3%
- Medicine925.3%
- Social Sciences617.6%
- Physical Sciences13.3%
- Computer Science13.3%
- 1Economics and Econometrics14% of their works
- 2Public Health, Environmental and Occupational Health13% of their works
- 3Infectious Diseases8% of their works
- 4Pediatrics, Perinatology and Child Health4% of their works
- 5Computational Theory and Mathematics3% of their works
- 6Education3% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Computational Drug Discovery Methods
- Biomedical Ethics and Regulation
- Meta-analysis and systematic reviews
- Synthesis of β-Lactam Compounds
- Antiplatelet Therapy and Cardiovascular Diseases
- HIV/AIDS drug development and treatment
Which keywords describe Dan Hartman's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Drug Development Costs, Generic Drugs, Clinical Trials, Meta-Analysis, Molecular Docking and PRISMA Statement.
- Synthesis
- Clopidogrel
- Aspirin
- Virtual Screening
- PRISMA Statement
- Meta-Analysis
- Generic Drugs
- Quality of Life
- Cost-effectiveness Analysis
- Drug Development Costs
- Clinical Trials
- Molecular Docking
- Stem Cell Regulation
- Antiretroviral Therapy
- Asymmetric Catalysis
- HIV Infection
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Cost-effectiveness Analysis81 topic
- Quality of Life81 topic
- Drug Development Costs41 topic
- Generic Drugs41 topic
- Clinical Trials31 topic
- Meta-Analysis31 topic
- Molecular Docking31 topic
- PRISMA Statement31 topic
- Stem Cell Regulation31 topic
- Virtual Screening31 topic
- Antiretroviral Therapy21 topic
- Aspirin21 topic
- Asymmetric Catalysis21 topic
- Clopidogrel21 topic
- HIV Infection21 topic
- Synthesis21 topic
Where does Dan Hartman work?
Dan Hartman's main affiliation in the publication record is Gates Foundation, United States.
How many publications and citations does Dan Hartman have?
OpenAlex counts 35 works and 430 citations for Dan Hartman, an h-index of 9, ranking #2,386,352 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dan Hartman. Posts are plain text and can be reported.